VEGFA and diabetic retinopathy: OSA has also been reported as an independent risk factor in the progression of diabetic retinopathy [10] and has been linked to non-responsiveness to intra-vitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for exudative AMD [11].